Updated EPS estimates from investment analysts for May 20 (AVBH, BAESY, BHB, BIGC, BIVI, BLCM, BLMN, BOLT, BOXL, BPTH)

0

EPS estimates updated by Investment Analysts for Friday, May 20:

Avidbank (OTCMKTS: AVBH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has a target price of $24.00 on the stock. According to Zacks, “Avidbank Holdings, Inc. is a chartered commercial bank locally owned and operated by the State of California. It provides financial solutions and services to its clients. The bank accepts deposits and offers commercial loans, construction loans, home loans, personal loans, business lines of credit and home equity lines of credit. It also offers foreign exchange services, free notary services, merchant services, travelers checks and mobile banking as well as other services. Avidbank Holdings, Inc., formerly known as Peninsula Bank Holding Co., is based in Palo Alto, California. “

BAE Systems (OTCMKTS:BAESY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BAE Systems is a global company committed to the development, delivery and support of advanced defense and aerospace systems in the air, on land and at sea. BAE Systems Inc. is the U.S. subsidiary of BAE Systems plc. Headquartered in Rockville, Maryland, BAE Systems Inc. consists of three operating groups that provide support and service solutions for current and future defense, intelligence and civilian systems; design, develop and manufacture a wide range of electronic systems and subsystems for military and commercial applications; and to design, develop, produce and provide aftermarket service for armored fighting vehicles, artillery systems and smart munitions.”

Bar Harbor Bankshares (NYSEAMERICAN: BHB) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The company currently has a target price of $28.00 on the stock. According to Zacks, “Bar Harbor Bankshares is a retail bank primarily serving individual customers, small retail establishments, seasonal accommodations, campgrounds and restaurants. The bank provides the normal banking services offered by a commercial bank, including checking accounts, NOW accounts, all forms of savings and time deposit accounts, individual retirement accounts, safe deposit boxes, collections , travelers checks, overnight deposit services, payroll direct deposit services, credit cards, personal money orders, mail and club bank accounts and car services at all offices. ”

BigCommerce (NASDAQ:BIGC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “BigCommerce Holdings Inc. provides an e-commerce platform as software. It mainly operates in San Francisco, Sydney and London. BigCommerce Holdings Inc. is headquartered in Austin. “

BioLife (NASDAQ: BIVI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BioVie Inc. is engaged in the development of drug therapies for liver disease. The Company’s product candidate includes BIV201, which is in clinical phase. BioVie Inc. is based in SANTA MONICA, California. “

Bellicum Pharmaceuticals (NASDAQ: BLCM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. He focuses on the discovery and development of cellular immunotherapies for various forms of cancer, including hematological and solid tumors, as well as orphan inherited blood disorders. The Company’s lead clinical product candidate is BPX-501, a complementary T-cell therapy in several Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castration-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas. “

Bloomin’ Brands (NASDAQ: BLMN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bloomin’ Brands, Inc. is a casual dining company with a portfolio of differentiated dining concepts. It offers five concepts: Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, Fleming’s Prime Steakhouse and Wine Bar and Roy’s. The Company offers its products and services through company-owned and franchised locations in the United States and internationally. Bloomin’ Brands, Inc. is based in Tampa, Florida. “

Bolt Biotherapeutics (NASDAQ: BOLT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development and commercialization of pharmaceutical products. The Company’s main product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood City, California. “

Light Box (NASDAQ:BOXL) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Boxlight Corporation is an educational technology development company. It offers interactive educational products that consist of software, classroom technology, professional development and support services. Boxlight Corporation is headquartered in Lawrenceville, Georgia. “

Bio-Path (NASDAQ:BPTH) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “BIO-PATH is developing state-of-the-art patented liposomal drug delivery systems, with two clinical-ready clinical cancer drug candidates and a third siRNA cancer drug in final preclinical development. Bio-Path’s drug delivery technology delivers nucleic acid drugs systemically throughout the human body via a simple intravenous infusion. The delivery technology can be applied to both double-stranded and single-stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where therapeutic disease targets are well characterized. “

Bank7 (NASDAQ:BSVN) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has a target price of $27.00 on the stock. According to Zacks, “Bank7 Corp. is the bank holding company of Bank7, operates as a community bank. It accepts deposits and provides loans, as well as card facilities, investments, certification of deposits, wealth management and online banking. Bank7 Corp. is headquartered in Oklahoma City. “

Bentley Systems (NASDAQ:BSY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The company currently has a target price of $36.00 on the stock. According to Zacks, “Bentley Systems Incorporated is a provider of software solutions for engineers, architects, geospatial professionals, builders and owner-operators for the design, construction and operation of infrastructure. Bentley Systems Incorporated is based in Exton, Pennsylvania. “

British Land (OTCMKTS: BTLCY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “The British Land Co. Plc is a real estate investment trust which owns, manages, finances and develops commercial properties. Its real estate portfolio includes retail parks, supermarkets, shopping malls, department stores, housing and offices. British Land Co. Plc is headquartered in London, UK. “

Capital Bancorp (NASDAQ:CBNK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Capital Bancorp Inc. is a bank holding company for Capital Bank, National Association. Capital Bank, National Association, is a national business-oriented banking association that provides banking services to businesses and individuals. The Company offers personal and commercial banking services, as well as cash management, commercial loans, consumer credit and residential mortgages and real estate loans. Capital Bancorp Inc. is based in Rockville, USA. “

Consensus Cloud Solutions (NASDAQ: CCSI) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Consensus Cloud Solutions Inc. is a provider of secure information delivery services with a Software-as-a-Service platform. It offers eFax, Consensus Unite, Consensus Signal, and jSign. Consensus Cloud Solutions Inc. is based in LOS ANGELES. “

Ceridian HCM (NYSE:CDAY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have a target price of $62.00 on the stock. According to Zacks, “Ceridian HCM Holding Inc. provides a human capital management software company. It provides human resources, payroll, benefits, workforce management, and talent management features. Ceridian HCM Holding Inc. is based in Minneapolis, USA. “

Celcuity (NASDAQ:CELC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have a target price of $6.25 on the stock. According to Zacks, “Celcuity Inc. is a cellular analysis company. It is committed to discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s live tumor cells to identify specific abnormal cell activity causing a patient’s cancer and targeted therapy. Celcuity Inc. is based in Minneapolis, USA. “



Receive daily news and reviews for Avidbank Holdings Inc. – Enter your email address below to receive a concise daily summary of breaking news and analyst notes for Avidbank Holdings Inc and related companies with MarketBeat.com’s free daily email newsletter.

Share.

Comments are closed.